Malova E - Search Results

1

Evaluating a game-based randomized experiment to increase melanoma identification among adults living in the U.S.

Carcioppolo N, Kim S, Sanchez M, Mao B, Malova E, Ryan A, Lun D, Ewing C, Hu S. Carcioppolo N, et al. Among authors: malova e. Soc Sci Med. 2022 Oct;310:115281. doi: 10.1016/j.socscimed.2022.115281. Epub 2022 Aug 18. Soc Sci Med. 2022. PMID: 36001916 Clinical Trial.

2

When guilt works: a comprehensive meta-analysis of guilt appeals.

Peng W, Huang Q, Mao B, Lun D, Malova E, Simmons JV, Carcioppolo N. Peng W, et al. Among authors: malova e. Front Psychol. 2023 Sep 28;14:1201631. doi: 10.3389/fpsyg.2023.1201631. eCollection 2023. Front Psychol. 2023. PMID: 37842697 Free PMC article.

3

Reducing Health Disparities Among African American and Black Caribbean Patients by Improving the Communication Practices of Clinical Research Coordinators.

Morgan SE, Harrison TR, Wright KO, Malova E, Deal B, Jia X. Morgan SE, et al. Among authors: malova e. Health Commun. 2024 Jun;39(7):1298-1309. doi: 10.1080/10410236.2023.2211740. Epub 2023 May 10. Health Commun. 2024. PMID: 37165558

4

Men have eating disorders too: an analysis of online narratives posted by men with eating disorders on YouTube.

Malova E, Dunleavy V. Malova E, et al. Eat Disord. 2022 Jul-Aug;30(4):437-452. doi: 10.1080/10640266.2021.1930338. Epub 2021 Aug 17. Eat Disord. 2022. PMID: 34402402

5

Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis.

Schramm C, Wedemeyer H, Mason A, Hirschfield GM, Levy C, Kowdley KV, Milkiewicz P, Janczewska E, Malova ES, Sanni J, Koo P, Chen J, Choudhury S, Klickstein LB, Badman MK, Jones D. Schramm C, et al. Among authors: malova es. JHEP Rep. 2022 Jul 21;4(11):100544. doi: 10.1016/j.jhepr.2022.100544. eCollection 2022 Nov. JHEP Rep. 2022. PMID: 36267872 Free PMC article.

6

Effects of ABCB1 rs1045642 polymorphisms on the efficacy and safety of amlodipine therapy in Caucasian patients with stage I-II hypertension.

Sychev D, Shikh N, Morozova T, Grishina E, Ryzhikova K, Malova E. Sychev D, et al. Among authors: malova e. Pharmgenomics Pers Med. 2018 Sep 20;11:157-165. doi: 10.2147/PGPM.S158401. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 30288082 Free PMC article.

7

[ANTIRETROVIRAL THERAPY AND THE RISK OF LIVER FIBROSIS PROGRESSION IN HIV/HCV COINFECTED PATIENTS].

Arystanbekova M, Balmasova I, Malova E, Sepiashvili R. Arystanbekova M, et al. Among authors: malova e. Georgian Med News. 2017 May;(266):58-63. Georgian Med News. 2017. PMID: 28628016 Russian.

8

[MECHANISMS OF INTERACTION OF VIRAL CAUSATIVE AGENTS IN PATIENTS CO-INFECTED WITH HUMAN IMMUNODEFICIENCY AND HEPATITIS C VIRUSES].

Balmasova IP, Aristanbekova MS, Malova ES, Sepiashvili RL. Balmasova IP, et al. Among authors: malova es. Zh Mikrobiol Epidemiol Immunobiol. 2016 Sep;(5):101-109. Zh Mikrobiol Epidemiol Immunobiol. 2016. PMID: 30695355 Review. Russian.

9

[MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B].

Balmasova IP, Sepiashvili RI, Malova ES. Balmasova IP, et al. Among authors: malova es. Zh Mikrobiol Epidemiol Immunobiol. 2016 Mar-Apr;(2):119-26. Zh Mikrobiol Epidemiol Immunobiol. 2016. PMID: 27228681 Russian.

10

Evidence-based pharmacogenetics: Is it possible?

Sychev DA, Malova EU. Sychev DA, et al. Among authors: malova eu. Int J Risk Saf Med. 2015;27 Suppl 1:S97-8. doi: 10.3233/JRS-150706. Int J Risk Saf Med. 2015. PMID: 26639733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page